Keyphrases
CD8+ T Cells
60%
Memory CD8+ T Cells
50%
COVID-19
27%
T Cell Response
27%
Lung
27%
Tissue-resident
27%
Tumor-specific
25%
Irreversible Electroporation
25%
Vaccination
20%
T Cells
18%
Lymph Node
18%
Tyrosinase-related Protein 2
13%
Self-tolerance
13%
Tumor Control
13%
P2X7 Receptor (P2X7R)
13%
Solid Tumors
13%
Adoptive Cell Therapy
13%
Checkpoint Immunotherapy
13%
Cryosurgery
13%
Cancer Antigen
13%
Tissue Damage
13%
Resident Memory
13%
Protective Immunity
13%
Antigen-specific
13%
MRNA Vaccine
13%
Tumor Antigen
13%
Memory CD4 T Cells
13%
Prostate Cancer
13%
Small Activating RNA (saRNA)
13%
Intranasal
13%
Epitope
13%
Cell Response
13%
Respiratory Infection
13%
Lung Infection
13%
Mediastinal Lymph Nodes
13%
Immunology
13%
Interleukin-7 (IL-7)
13%
Interleukin-15 (IL-15)
13%
Adaptation
13%
Respiratory mucosa
13%
Tumor
12%
Weight Loss
11%
Non-lymphoid Tissues
10%
Focal Therapy
9%
Healthy Tissue
9%
Memory T Cells
9%
Intramuscular Immunization
9%
Neutralizing Abs
9%
Cellular Immunity
9%
K18-hACE2 Mice
9%
Immunology and Microbiology
Cytotoxic T-Cell
100%
T Cell
54%
Infection
47%
Severe Acute Respiratory Syndrome Coronavirus 2
27%
Electroporation
27%
Tumor Antigen
27%
Lymph Node
27%
Immunotherapy
22%
Epitope
17%
Memory T Cell
17%
Nucleoprotein
16%
Respiratory Mucosa
15%
Immune Tolerance
13%
Spike
13%
T-Helper Cell
13%
Virus Nucleocapsid
13%
Prostate
13%
Wild Type
13%
Interleukin 7
13%
Cytokine
13%
COVID-19
12%
Adoptive Immunity
11%
Humoral Immunity
11%
Interleukin 15
11%
Lymphoid Tissue
10%
Gene Expression
9%
CD25
9%
Influenza
8%
Immune System
8%
CTLA-4
6%
Tumor Immunity
6%
Immunostimulation
6%
Stem Cell
6%
CD8
6%
Influenzavirus A
6%
Follicular B Helper T Cells
6%
Neutralizing Antibody
6%
Antibody Blood Level
6%
Immune Checkpoint Inhibitor
6%
T Cell Activation
5%
Cell Lysate
5%
Pulse Rate
5%
Cancer Immunotherapy
5%
